Dow Up0.51% Nasdaq Up0.24%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
191.02 Down 1.53(0.79%) Nov 21, 4:00PM EST
|After Hours : 191.02 0.00 (0.00%) Nov 21, 5:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 555,146   512,495   566,616   441,909  
Cost of Revenue51,858  39,626  32,939  51,552  
Gross Profit 503,288   472,869   533,677   390,357  
Operating Expenses
Research Development100,661  92,554  191,457  85,785  
Selling General and Administrative157,665  159,477  129,291  134,819  
Non Recurring8,303  1,989  3,426  31,576  
Others -   -   -  105  
Total Operating Expenses -   -   -  252,285  
Operating Income or Loss 236,659   218,849   209,503   138,072  
Income from Continuing Operations
Total Other Income/Expenses Net205  512  3,471  712  
Earnings Before Interest And Taxes236,864  219,361  212,974  138,784  
Interest Expense655  715  1,063  807  
Income Before Tax236,209  218,646  211,911  137,977  
Income Tax Expense58,478  52,151  52,557  156,969  
Minority Interest -   -   -   -  
Net Income From Continuing Ops177,731  166,495  159,354  (18,992)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 177,731   166,495   159,354   (18,992)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 177,731   166,495   159,354   (18,992)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.